Dr. Jessica Rose is a Canadian molecular biologist. She was also trained in biostatistics during her PhD and hated it. But since the vaccine rollouts over two years ago, she has been analyzing statistics every day. “I really still loathe statistics,” Rose said, yet that hasn’t stopped her from analyzing the U.S. Vaccine Adverse Event…
COVID VAERS Inconsistencies: Backlogged Data, Causal Data, Data Removal
Doctor Who Promoted COVID Shots on TV Calls for Global Stop to COVID-19 Vaccines: Study
Lately, Dr. Aseem Malhotra, a British cardiologist who was previously supportive of COVID-19 vaccines has been the topic of breaking news stories for demanding a global stop to the distribution of the same vaccines he once promoted. It was certainly a first for a doctor who had heavily promoted the vaccines to publicly demand a…
Pfizer, Moderna Ask US Regulators for Emergency Authorization for New Boosters for Children
Pfizer and Moderna have formally asked U.S. regulators to grant emergency authorization for new COVID-19 vaccine boosters for children as young as five. Pfizer and its partner BioNTech submitted a request to the U.S. Food and Drug Administration (FDA) on Sept. 26, several days after Moderna submitted a request to the FDA. The FDA authorized…
Top Pro-Vaccine Doctor Calls for Global Pause of Messenger RNA COVID-19 Vaccines
A doctor who promoted COVID-19 vaccines in 2020 and 2021 is now calling for health authorities around the world to pause administration of two of the most-widely utilized COVID-19 vaccines, asserting that the benefits from the vaccines may not outweigh the risks. “There is more than enough evidence—I would say the evidence is overwhelming—to pause…
Updated Moderna COVID-19 Booster Didn’t Improve Clinical Efficacy: Study
Moderna’s updated COVID-19 vaccine was not more effective at preventing COVID-19 infection, according to a new study. Researchers funded by Moderna analyzed the updated shot, which contains elements of the Wuhan virus strain and the BA.1 strain, in comparison to the old booster, which was only targeted at the Wuhan variant. They recorded more participants…
Spike Protein From Infection and Vaccines Contributing to Autoimmune Diseases, Studies Suggest
Photos of Debbie Botzum-Pearson before (left) and after neuromyelitis optica (Courtesy of Debbie Botzum-Pearson). On the morning of Jan. 15, 2022, Debbie Botzum-Pearman, who had been a strong healthy woman for 66 years, woke up paralyzed from the chest down. On Sep. 13, 2022, nearly nine months later, she managed to stand up without assistance…
Western University to Delay COVID Booster Mandate to Early 2023
Western University said on Sept. 6 it will delay imposing a COVID-19 booster requirement due to Health Canada approving a new bivalent vaccine. The university in London, Ontario, announced in late August it would impose the booster on staff, faculty, students, and some visitors. It says the measures are “aimed at preserving the in-person learning…
FDA Authorizes Updated COVID-19 Boosters Despite Lack of Clinical Data
U.S. drug regulators on Aug. 31 authorized COVID-19 vaccine booster shots despite no clinical trial data being available for the updated formulations. The U.S. Food and Drug Administration (FDA) granted emergency use authorization to Moderna and Pfizer for their updated boosters. The original vaccines were based on components of the Wuhan strain of the virus…
Inflammatory mRNA Nanoparticles Inhibits and Alters Immune Response: Pre-Print Study
A recent preprint study has shed light on why adverse events have been observed following a COVID-19 messenger RNA (mRNA) vaccination. The study, led by researchers from Thomas Jefferson University found that the lipid nanoparticles (LNPs) used to transport mRNA in COVID-19 vaccines could “inhibit” and “alter” immune responses in mice. LNPs are shells of lipids…
Inflammatory mRNA Nanoparticles Inhibit and Alter Immune Response: Pre-Print Study
A recent preprint study has shed light on why adverse events have been observed following a COVID-19 messenger RNA (mRNA) vaccination. The study, led by researchers from Thomas Jefferson University found that the lipid nanoparticles (LNPs) used to transport mRNA in COVID-19 vaccines could “inhibit” and “alter” immune responses in mice. LNPs are shells of lipids…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`